Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization program
A health worker wearing a protective mask works in a lab during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, U.S.
Eva Marie Uzcategui | Bloomberg | Getty Images
European drugmakers Sanofi and GlaxoSmithKline will provide 200 million doses of their Covid-19 vaccine to the World Health Organization’s global immunization partnership COVAX, which seeks to ensure coronavirus vaccines are distributed equitably across the world, the companies announced Wednesday.
Global health organizations including the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations and the WHO are leading the COVAX effort, which is focused on first vaccinating the most high-risk people in every country. The deal is contingent on the vaccine winning regulatory approval, the companies said in a statement.
The initiative aims to deliver 2 billion doses of the vaccine by the …continued .
[Source: CNBC News]